Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome

Background: Growth arrest-specific factor 6 (GAS6) and the Tyro3, AXL, and MERTK (TAM) receptors counterbalance pro-inflammatory responses. AXL is a candidate receptor for SARS-CoV-2, particularly in the respiratory system, and the GAS6/AXL axis is targeted in current clinical trials against COVID-1...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomedicines
Autors principals: Morales, Albert, Rojo Rello, Silvia, Cristóbal, Helena, Fiz-López, Aida, Arribas, Elisa, Marí, Montserrat, Tutusaus, Anna, de la Cal-Sabater, Paloma, Nicolaes, Gerry A.F., Ortiz-Pérez, José T., Bernardo, David, García de Frutos, Pablo
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Communication
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8065652/
https://ncbi.nlm.nih.gov/pubmed/33810394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040335
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars